Research, research support, and administrative support service requirements at the federally funded research and development center (ffrdc) at the frederick national laboratory for cancer research…

Ended Awarded Last action

Contract number
75N91019F00132
Awardee
Awarding agency
Obligated
$24,270,119

Award facts

Opportunity
  • N02CO7240681 Solicitation number
Contract value 75% obligated
  • $24,270,119.00 Current, with exercised options
  • $32,441,980.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 $1,052,226
Funding Only Action P00003 $6,500,000
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $16,717,893

About this award

The National Institute of Allergy and Infectious Diseases issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2019, with a ceiling value of $32.4 million under a cost-plus-fixed-fee pricing structure for research, research support, and administrative support services at the Frederick National Laboratory for Cancer Research (FNLCR), an FFRDC operated by Leidos.

Performance is at the Frederick, MD facility, with an ultimate completion date of September 11, 2020. The order supports NIAID VRC operational requirements. In fiscal year 2020, the order invoiced $19.6 million in government-paid labor across a teaming structure that included three subcontractors.

Description

Research, research support, and administrative support service requirements at the federally funded research and development center (ffrdc) at the frederick national laboratory for cancer research (fnlcr) for the national institute of allergy and INF

Quick answers

Who was awarded contract 75N91019F00132?

75N91019F00132 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2019.

How much is contract 75N91019F00132 worth?

The government has obligated $24,270,119 on 75N91019F00132. Its potential value, with all options, is $32,441,980.

Which agency awarded contract 75N91019F00132?

National Cancer Institute (National Institutes of Health) awarded 75N91019F00132, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).

Is contract 75N91019F00132 an order under another contract?

Yes. 75N91019F00132 is a delivery order under 75N91019D00024, an indefinite delivery contract.

Was contract 75N91019F00132 competed?

The extent of competition for 75N91019F00132 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award